Clinical Trial Update: Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Clinical trial update for a Phase Ib study of SAR650984 in combination with carfilzomib for relapsed or refractory multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Kyprolis (carfilzomib)
• SAR650984 (SAR650984)

Snippet

Sponsor: Thomas Martin, MD | Conditions: Multiple Myeloma | Phase 1 | Status: ACTIVE_NOT_RECRUITING